Complete response in a case of CD30+ primary cutaneous diffuse large B-cell lymphoma of the scalp treated with brentuximab vedotin - 09/05/15
Xiaolong Zhou, MD, MS, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, United States; Mildreth Amelyn Cid Garza, MD, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, United States; Adriane Vega, MD, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, United States; Sadegh Amini, MD, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, United States; Jose Ollague, MD, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, United States; Andrew Ross, MD, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, United States; Javier Alonso-Llamazares, MD, PhD, Department of Dermatology, Bruce W. Carter Veterans Affairs Medical Center, Miami, FL, United States
Le texte complet de cet article est disponible en PDF. Commercial support: None identified. |
Vol 72 - N° 5S1
P. AB157 - mai 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?